Literature DB >> 17572676

Tissue-specific and reversible RNA interference in transgenic mice.

Ross A Dickins1, Katherine McJunkin, Eva Hernando, Prem K Premsrirut, Valery Krizhanovsky, Darren J Burgess, Sang Yong Kim, Carlos Cordon-Cardo, Lars Zender, Gregory J Hannon, Scott W Lowe.   

Abstract

Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline (tet)-responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference (RNAi) in mice. Transgenic mice harboring a tet-responsive RNA polymerase II promoter driving a microRNA-based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue-specific 'tet-on' or 'tet-off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue-specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572676      PMCID: PMC4595852          DOI: 10.1038/ng2045

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  39 in total

Review 1.  Conditional control of gene expression in the mouse.

Authors:  M Lewandoski
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells.

Authors:  Frank Stegmeier; Guang Hu; Richard J Rickles; Gregory J Hannon; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

4.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

5.  Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis.

Authors:  Manjeet K Rao; John Pham; J Saadi Imam; James A MacLean; Deepa Murali; Yasuhide Furuta; Amiya P Sinha-Hikim; Miles F Wilkinson
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

6.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

7.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

8.  NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis.

Authors:  F Kühnel; L Zender; Y Paul; M K Tietze; C Trautwein; M Manns; S Kubicka
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

9.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

10.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

View more
  90 in total

1.  Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance.

Authors:  Maria Hinterberger; Martin Aichinger; Olivia Prazeres da Costa; David Voehringer; Reinhard Hoffmann; Ludger Klein
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

Review 2.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

3.  The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation.

Authors:  Xiaolei Ding; Xiaoying Wang; Stephanie Sontag; Jie Qin; Paul Wanek; Qiong Lin; Martin Zenke
Journal:  Stem Cells Dev       Date:  2014-01-21       Impact factor: 3.272

4.  Breast Cancer Metastasis.

Authors:  Mi Young Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A system for Cre-regulated RNA interference in vivo.

Authors:  Patrick Stern; Sophie Astrof; Stefan J Erkeland; Joshua Schustak; Phillip A Sharp; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

Review 6.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

7.  Multipurpose modular lentiviral vectors for RNA interference and transgene expression.

Authors:  Venu Kesireddy; Peter F M van der Ven; Dieter O Fürst
Journal:  Mol Biol Rep       Date:  2009-10-02       Impact factor: 2.316

8.  Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.

Authors:  Manuel Gutiérrez-Aguilar; Diana L Douglas; Anne K Gibson; Timothy L Domeier; Jeffery D Molkentin; Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2014-04-21       Impact factor: 5.000

9.  MicroRNA: An emerging therapeutic target and intervention tool.

Authors:  Zhen Liu; Alhousseynou Sall; Decheng Yang
Journal:  Int J Mol Sci       Date:  2008-06-13       Impact factor: 6.208

10.  UBF levels determine the number of active ribosomal RNA genes in mammals.

Authors:  Elaine Sanij; Gretchen Poortinga; Kerith Sharkey; Sandy Hung; Timothy P Holloway; Jaclyn Quin; Elysia Robb; Lee H Wong; Walter G Thomas; Victor Stefanovsky; Tom Moss; Lawrence Rothblum; Katherine M Hannan; Grant A McArthur; Richard B Pearson; Ross D Hannan
Journal:  J Cell Biol       Date:  2008-12-22       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.